ID

13701

Description

Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01433133

Link

https://clinicaltrials.gov/show/NCT01433133

Keywords

  1. 2/29/16 2/29/16 -
Uploaded on

February 29, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis C NCT01433133

Eligibility Hepatitis C NCT01433133

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed patient consent form
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
genotype 3 chronic hcv with detectable hcv rna
Description

Hepatitis C, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0524910
no previous treatment for hcv infection
Description

infection Hepatitis C

Data type

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0019196
hepatitis b and human immunodeficiency virus negative at screening visit
Description

Hepatitis B test negative; human immunodeficiency virus negative

Data type

boolean

Alias
UMLS CUI [1]
C1611173
UMLS CUI [2]
C0481430
able and willing to follow contraception requirements
Description

Contraception status

Data type

boolean

Alias
UMLS CUI [1]
C0420837
screening laboratory values, test, and physical exam within acceptable ranges
Description

physical examination; laboratory

Data type

boolean

Alias
UMLS CUI [1]
C0031809
UMLS CUI [2]
C0022877
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
current enrollment in another investigational device or drug study
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
anticipated inability to complete all clinic visits and comply with study procedures
Description

compliance

Data type

boolean

Alias
UMLS CUI [1]
C1321605
history of, or any current medical condition, which could impact the safety of the subject during the study
Description

Compliance behavior Limited Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
autoimmune hepatitis, suspected hepatocellular carcinoma, decompensated liver disease, or other known liver disease other than hcv
Description

autoimmune hepatitis; hepatocellular carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0241910
UMLS CUI [2]
C2239176
alcoholism or substance abuse with <6 documented months of sobriety
Description

Substance Use Disorder

Data type

boolean

Alias
UMLS CUI [1]
C0038586
known allergy or sensitivity to interferons or ribavirin
Description

hypersensitivity ribavirin

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0035525
any other condition that, in the opinion of the investigator, would make the subject unsuitable for enrollment or could interfere with the subject participating in and completing the study
Description

Compliance behavior Limited Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488

Similar models

Eligibility Hepatitis C NCT01433133

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
signed patient consent form
boolean
C0021430 (UMLS CUI [1])
Hepatitis C, Chronic
Item
genotype 3 chronic hcv with detectable hcv rna
boolean
C0524910 (UMLS CUI [1])
infection Hepatitis C
Item
no previous treatment for hcv infection
boolean
C3714514 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
Hepatitis B test negative; human immunodeficiency virus negative
Item
hepatitis b and human immunodeficiency virus negative at screening visit
boolean
C1611173 (UMLS CUI [1])
C0481430 (UMLS CUI [2])
Contraception status
Item
able and willing to follow contraception requirements
boolean
C0420837 (UMLS CUI [1])
physical examination; laboratory
Item
screening laboratory values, test, and physical exam within acceptable ranges
boolean
C0031809 (UMLS CUI [1])
C0022877 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
current enrollment in another investigational device or drug study
boolean
C2348568 (UMLS CUI [1])
compliance
Item
anticipated inability to complete all clinic visits and comply with study procedures
boolean
C1321605 (UMLS CUI [1])
Compliance behavior Limited Comorbidity
Item
history of, or any current medical condition, which could impact the safety of the subject during the study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
autoimmune hepatitis; hepatocellular carcinoma
Item
autoimmune hepatitis, suspected hepatocellular carcinoma, decompensated liver disease, or other known liver disease other than hcv
boolean
C0241910 (UMLS CUI [1])
C2239176 (UMLS CUI [2])
Substance Use Disorder
Item
alcoholism or substance abuse with <6 documented months of sobriety
boolean
C0038586 (UMLS CUI [1])
hypersensitivity ribavirin
Item
known allergy or sensitivity to interferons or ribavirin
boolean
C0020517 (UMLS CUI [1,1])
C0035525 (UMLS CUI [1,2])
Compliance behavior Limited Comorbidity
Item
any other condition that, in the opinion of the investigator, would make the subject unsuitable for enrollment or could interfere with the subject participating in and completing the study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial